The kids are not all right: The urgent need to expand effective behavioral health services for children and youth Vikki Wachino, Richard G. Frank, Keith Humphreys, and John O’Brien Wednesday, December 15, 2021
Regulating drug prices while increasing innovation Rena Conti, Richard G. Frank, and Jonathan Gruber Wednesday, December 1, 2021
Comments on Senate Finance Committee’s call for proposals to address mental health needs Richard G. Frank and Sherry Glied Wednesday, November 17, 2021
Addressing the trade-off between lower drug prices and incentives for pharmaceutical innovation Rena Conti, Richard G. Frank, and Jonathan Gruber Monday, November 15, 2021
Making workplaces better for people struggling with mental health will make work better for everyone Sherry Glied and Richard G. Frank Monday, November 1, 2021
Comments on “A bold vision for America’s mental well being” Richard G. Frank and Sherry Glied Tuesday, October 19, 2021
Paying for cancer drugs that prove their benefit Richard G. Frank and Ezekiel Emanuel Thursday, October 14, 2021
Evidence for addressing the opioid epidemic: Rounding out the picture Colleen Barry and Richard G. Frank Wednesday, February 6, 2019
High-priced drugs in Medicare Part D: Diagnosis and prescription Richard G. Frank and Richard J. Zeckhauser Thursday, January 4, 2018
Pharmaceutical industry profits and research and development Richard G. Frank and Paul B. Ginsburg Friday, November 17, 2017
